CAS No.:563-12-2
Name: Ethion
Details Introduction
TOXICITY DATA with REFERENCE:
1. |
orl-inf TDLo:15,700 µg/kg:CNS,PNS,MET |
TXMDAX Texas Medicine. 63 (1967),71. | ||
2. |
orl-hmn TDLo:100 µg/kg:BIO |
TXAPA9 Toxicology and Applied Pharmacology. 22 (1972),286. | ||
3. |
orl-rat LD50:13 mg/kg |
PHJOAV Pharmaceutical Journal. 185 (1960),361. | ||
4. |
ihl-rat LC50:864 mg/m3 |
FMCHA2 Farm Chemicals Handbook .(Meister Publishing,Willoughy, OH.: )1991,C128. | ||
5. |
skn-rat LD50:62 mg/kg |
TXAPA9 Toxicology and Applied Pharmacology. 14 (1969),515. | ||
6. |
ipr-rat LD50:26 mg/kg |
PSEBAA Proceedings of the Society for Experimental Biology and Medicine. 129 (1968),699. | ||
7. |
orl-mus LD50:40 mg/kg |
85DPAN Wirksubstanzen der Pflanzenschutz und Schadlingsbekampfungsmittel Werner Perkow,Berlin, Germany.: Verlag Paul Parey,1971/76. | ||
8. |
ipr-mus LD50:35 mg/kg |
PSEBAA Proceedings of the Society for Experimental Biology and Medicine. 129 (1968),699. | ||
9. |
skn-rbt LD50:890 mg/kg |
TobJS# Personal Communication to the Editor, Toxic Substances List from Dr. J.S. Tobin, Director, Health and Safety, FMC Corporation, New York, NY 14103, November 9, 1973 9NOV73 . |
Consensus Reports:
EPA: Farm Worker Field Reentry FEREAC Federal Register. 39 (1974),16888. . EPA Genetic Toxicology Program. EPA Extremely Hazardous Substances List.
SAFETY PROFILE:
Poison by ingestion, skin contact, and intraperitoneal routes. Human systemic effects by ingestion: flaccid paralysis without anesthesia, motor activity changes, fever, and inhibition of cholinesterase. When heated to decomposition it emits highly toxic fumes of SOx and POx. See also PARATHION.
Standards and Recommendations:
OSHA PEL: TWA 0.4 mg/m3 (skin)
ACGIH TLV: TWA 0.05 mg/m3 (skin); Not Classifiable as a Human Carcinogen
Analytical Methods:
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione